209 related articles for article (PubMed ID: 16632868)
1. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
[TBL] [Abstract][Full Text] [Related]
2. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.
Tong M; Tai HH
Arch Biochem Biophys; 2005 Mar; 435(1):50-5. PubMed ID: 15680906
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
[TBL] [Abstract][Full Text] [Related]
4. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
5. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Biochem Pharmacol; 2006 Sep; 72(6):701-9. PubMed ID: 16844092
[TBL] [Abstract][Full Text] [Related]
7. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
9. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
[TBL] [Abstract][Full Text] [Related]
10. [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts].
Jiang LD; Wang HZ; Zhao FD; Guo JS; Bao CD; Zou HJ; Wang JY
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2925-8. PubMed ID: 18261308
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
[TBL] [Abstract][Full Text] [Related]
12. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells.
Chen KH; Weng MS; Lin JK
Biochem Pharmacol; 2007 Jan; 73(2):215-27. PubMed ID: 17067555
[TBL] [Abstract][Full Text] [Related]
13. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PKC, p38 MAPK and AP-2 in IL-1beta-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells.
Chen P; Cai Y; Yang ZG; Zhou R; Zhang GS; Domann F; Fang X
Respirology; 2006 Jan; 11(1):18-23. PubMed ID: 16423197
[TBL] [Abstract][Full Text] [Related]
16. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
17. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.
Tai HH; Tong M; Ding Y
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):203-8. PubMed ID: 17481556
[TBL] [Abstract][Full Text] [Related]
18. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128
[TBL] [Abstract][Full Text] [Related]
19. [Effects of RNA interference of COX-2 gene expression on malignant proliferation of A549 cells in vitro].
Li WY; Wang H; Lai BT; Yang XH; Zhang CY
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):904-8. PubMed ID: 18478928
[TBL] [Abstract][Full Text] [Related]
20. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.
Subramaniam D; Ramalingam S; May R; Dieckgraefe BK; Berg DE; Pothoulakis C; Houchen CW; Wang TC; Anant S
Gastroenterology; 2008 Apr; 134(4):1070-82. PubMed ID: 18395088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]